Cargando…
Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na(V)1.5‐mediated EMT and FAK/Paxillin signaling pathway
Lidocaine, one of the most commonly used local anesthetics during surgery, has been reported to suppress cancer cell growth via blocking voltage‐gated sodium channels (VGSCs). VGSC 1.5 (Na(V)1.5) is highly expressed in invasive cancers including ovarian cancer. This study aims to investigate whether...
Autores principales: | Liu, Chang, Yu, Ming, Li, Yi, Wang, Hao, Xu, Chuanya, Zhang, Xiaoqing, Li, Min, Guo, Hongyan, Ma, Daqing, Guo, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826465/ https://www.ncbi.nlm.nih.gov/pubmed/33280262 http://dx.doi.org/10.1002/cam4.3621 |
Ejemplares similares
-
Multiple paxillin binding sites regulate FAK function
por: Scheswohl, Danielle M, et al.
Publicado: (2008) -
FAK and paxillin, two potential targets in pancreatic cancer
por: Kanteti, Rajani, et al.
Publicado: (2016) -
FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells
por: Hu, Ying-Li, et al.
Publicado: (2014) -
Nudel and FAK as Antagonizing Strength Modulators of Nascent Adhesions through Paxillin
por: Shan, Yongli, et al.
Publicado: (2009) -
Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization
por: Hong, Kyoung-Ok, et al.
Publicado: (2019)